Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Joost

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Genome Biology|November 14, 2002
Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligandsPatrick Joost, Axel Methner
Free Radical Research|October 20, 2006
Induction of Bcl-2 by functional regulation of G-protein coupled receptors protects from oxidative glutamate toxicity by increasing glutathioneMert Sahin, Ambrish Saxena, Patrick Joost, et al.
BMC Clinical Pathology|December 18, 2013
Efficient and reproducible identification of mismatch repair deficient colon cancer: validation of the MMR index and comparison with other predictive modelsPatrick Joost, Pär-Ola Bendahl, Britta Halvarsson, et al.
Urology|September 20, 2015
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 MutationsPatrick Joost, Christina Therkildsen, Mev Dominguez-Valentin, et al.
BMC Urology|March 26, 2016
Frequent mismatch-repair defects link prostate cancer to Lynch syndromeMev Dominguez-Valentin, Patrick Joost, Christina Therkildsen, et al.
Leukemia & Lymphoma|February 17, 2012
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphomaKarin Rydström, Patrick Joost, Mats Ehinger, et al.
Leukemia & Lymphoma|July 3, 2010
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapyKarin Rydström, Johan Linderoth, Heidi Nyman, et al.
Diagnostic Pathology|June 28, 2014
Heterogenous mismatch-repair status in colorectal cancerPatrick Joost, Nynke Veurink, Susanne Holck, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 8, 2003
Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain developmentAtanas Ignatov, Julia Lintzel, Irm Hermans-Borgmeyer, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS CohortDaniel Bengtsson, Patrick Joost, Christos Aravidis, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Genome Biology|November 14, 2002
Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligandsPatrick Joost, Axel Methner
Free Radical Research|October 20, 2006
Induction of Bcl-2 by functional regulation of G-protein coupled receptors protects from oxidative glutamate toxicity by increasing glutathioneMert Sahin, Ambrish Saxena, Patrick Joost, et al.
BMC Clinical Pathology|December 18, 2013
Efficient and reproducible identification of mismatch repair deficient colon cancer: validation of the MMR index and comparison with other predictive modelsPatrick Joost, Pär-Ola Bendahl, Britta Halvarsson, et al.
Urology|September 20, 2015
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 MutationsPatrick Joost, Christina Therkildsen, Mev Dominguez-Valentin, et al.
BMC Urology|March 26, 2016
Frequent mismatch-repair defects link prostate cancer to Lynch syndromeMev Dominguez-Valentin, Patrick Joost, Christina Therkildsen, et al.
Leukemia & Lymphoma|February 17, 2012
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphomaKarin Rydström, Patrick Joost, Mats Ehinger, et al.
Leukemia & Lymphoma|July 3, 2010
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapyKarin Rydström, Johan Linderoth, Heidi Nyman, et al.
Diagnostic Pathology|June 28, 2014
Heterogenous mismatch-repair status in colorectal cancerPatrick Joost, Nynke Veurink, Susanne Holck, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 8, 2003
Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain developmentAtanas Ignatov, Julia Lintzel, Irm Hermans-Borgmeyer, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS CohortDaniel Bengtsson, Patrick Joost, Christos Aravidis, et al.
Pageof 1